This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Prior to this approval, the duration of treatment with Izervay had been limited to 12 months. The expanded labeling provides efficacy and safety data for up to 2 years of dosing from the phase 3 ...

are based on a more extensive database, with more than 30 years of additional rainfall data and data from extra rainfall stations; are more accurate estimates, combining contemporary statistical ...

Lower eyelid malposition, a commonly encountered eyelid disorder, is often linked to discomfort, visual disturbances, and cosmetic concerns. Various treatment modalities have been employed to address ...